SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?


To: William F. Wager, Jr. who wrote (1169)4/19/1999 10:37:00 PM
From: Rob Loney  Read Replies (2) | Respond to of 1580
 
A sector that has run out of good stories.

The kind of growth seen in WLA, PFE, MRK has been driven by good
stories. Lipitor, Viagra & Cozaar, respectively. I don't think
that MRK's Cox-2 will have much immediate impact on MRK shares. Searle is doing great with their Cox-2, and MTC hasn't moved...at least not upwards.